Inventor · disambiguated record
Peter Pavlik
Also filed as: PAVLIK PETER
13 granted patents·5 pending applications·71 citations·filing 2003–2024
90Inventor score
Files withAPTEVO RES & DEVELOPMENT LLC6MEDIMMUNE LTD5MEDIMMUNE LLC3HORIZON THERAPEUTICS IRELAND DAC2UNIV CALIFORNIA1
Top patents by PatentIndex Score
18 records- 0194US9938356B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2015·Granted Apr 10, 2018·26 cites·9 claims
- 0291US10730934B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2018·Granted Aug 4, 2020·6 cites·21 claims
- 0391US10287362B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2018·Granted May 14, 2019·10 cites·15 claims
- 0490US9879070B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2013·Granted Jan 30, 2018·17 cites·6 claims
- 0588US11939392B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Granted Mar 26, 2024·1 cites·15 claims
- 0688US10676533B2Methods of treatment of CD123 overexpressing disordersAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Jun 9, 2020·4 cites·9 claims
- 0784US11447543B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2020·Granted Sep 20, 2022·1 cites·12 claims
- 0883US11242400B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Granted Feb 8, 2022·2 cites·33 claims
- 0983US2025122276A1Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 1082US12441798B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2024·Granted Oct 14, 2025·0 cites·15 claims
- 1181US10556968B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Feb 11, 2020·2 cites·8 claims
- 1280US11512127B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesVIELA BIO INC·Filed 2019·Granted Nov 29, 2022·2 cites·21 claims
- 1379US2023340152A1Binding molecules specific for cd73 and uses thereofMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 1478US12209123B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2022·Granted Jan 28, 2025·0 cites·19 claims
- 1572US11525012B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Dec 13, 2022·0 cites·6 claims
- 1657US2024301086A1Tumor-associated antigens and cd3-binding proteins, related compositions, and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Application pending·0 cites
- 1750US2022242962A14-1bb and ox40 binding proteins and related compositions and methods, antibodies against 4-1bb, antibodies against ox40APTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 1844US2005064509A1Use of templated self assembly to create novel multifunctional speciesUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Pavlik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →